Quarterly Results • Search Archive
Sai Parenterals Limited
Results, Financials & Updates
Follow Sai Parenterals Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Sai Parenterals Limited: latest results and financials
About the business in Nivata's latest coverage
Sai Parenterals Limited is an integrated, IP-led pharmaceutical enterprise operating across contract development and manufacturing (CDMO) services for Indian and multinational clients, alongside branded generic formulations sold domestically and exported to regulated and semi-regulated markets. The company's commercial portfolio covers 302 products spanning nine therapeutic areas, supported by over 599 approved product registrations and 67 dossiers under development. Manufacturing infrastructure includes six facilities, comprising five in India and one in Australia.
Quarter history
Sai Parenterals Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹178.67 Cr · PAT ₹7.92 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.